Corrigendum: Evaluation of cerebrospinal fluid neurofilament light chain levels in multiple sclerosis and non-demyelinating diseases of the central nervous system: clinical and biochemical perspective. Biomol Biomed [Internet]. 2023Mar.16 [cited 2023Nov.30];23(2):351. Available from: https://www.bjbms.org/ojs/index.php/bjbms/article/view/8354